147 related articles for article (PubMed ID: 36456792)
21. Single-institution outcomes after excision of benign phyllodes tumors: low recurrence risk even with positive margins.
Balogun Z; Steiman JG; Schwartz JL; Lee JS; Soran A; Johnson RR; McAuliffe PF; Diego EJ
Breast Cancer Res Treat; 2023 Apr; 198(3):569-572. PubMed ID: 36807012
[TBL] [Abstract][Full Text] [Related]
22. A retrospective review of phyllodes tumours of the breast: A single institution experience.
Ganesh V; Drost L; Lee J; Wan BA; Zhang L; Rakovitch E; Vesprini D; Slodkowska E; Zeng KL; Sousa P; Yee C; Lam H; Chow E
Breast; 2018 Apr; 38():52-57. PubMed ID: 29232600
[TBL] [Abstract][Full Text] [Related]
23. Management of phyllodes breast tumors.
Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
[TBL] [Abstract][Full Text] [Related]
24. Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence.
Yu CY; Huang TW; Tam KW
Int J Surg; 2022 Nov; 107():106969. PubMed ID: 36328344
[TBL] [Abstract][Full Text] [Related]
25. Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast.
de Roos WK; Kaye P; Dent DM
Br J Surg; 1999 Mar; 86(3):396-9. PubMed ID: 10201787
[TBL] [Abstract][Full Text] [Related]
26. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases.
Reinfuss M; Mituś J; Duda K; Stelmach A; Ryś J; Smolak K
Cancer; 1996 Mar; 77(5):910-6. PubMed ID: 8608483
[TBL] [Abstract][Full Text] [Related]
27. Margin status impact on recurrence of phyllodes tumors in high-risk groups: a retrospective observational study.
Ranjbar A; Zangouri V; Shokripour M
BMC Cancer; 2024 Jan; 24(1):48. PubMed ID: 38195454
[TBL] [Abstract][Full Text] [Related]
28. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of phyllodes tumours of the breast: evaluation of 66 cases and literature review].
Lohmeyer JA; Huster N; Lühr C; Lindner C; Wittig KS; Keck MK
Handchir Mikrochir Plast Chir; 2021 Apr; 53(2):159-167. PubMed ID: 32785910
[TBL] [Abstract][Full Text] [Related]
30. The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08).
Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
Clin Breast Cancer; 2019 Oct; 19(5):345-353.e2. PubMed ID: 31103280
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of benign phyllodes tumours of the breast: Is wide local excision really necessary?
Qian Y; Quan ML; Ogilvi T; Bouchard-Fortier A
Can J Surg; 2018 Dec; 61(6):17617. PubMed ID: 30265644
[TBL] [Abstract][Full Text] [Related]
32. Local recurrence after breast-conserving therapy for phyllodes tumors: A 15-year retrospective review.
Cervoni GE; Quintana L; Erlinger AL; Neo DT; Recht A; Schnitt SJ; Hacker MR; Sharma R
Breast J; 2020 May; 26(5):988-990. PubMed ID: 31814215
[TBL] [Abstract][Full Text] [Related]
33. How Wide Should Margins Be for Phyllodes Tumors of the Breast?
Tremblay-LeMay R; Hogue JC; Provencher L; Poirier B; Poirier É; Laberge S; Diorio C; Desbiens C
Breast J; 2017 May; 23(3):315-322. PubMed ID: 27901301
[TBL] [Abstract][Full Text] [Related]
34. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors.
Barth RJ; Wells WA; Mitchell SE; Cole BF
Ann Surg Oncol; 2009 Aug; 16(8):2288-94. PubMed ID: 19424757
[TBL] [Abstract][Full Text] [Related]
35. Phyllodes tumor of the breast: a retrospective study of the impact of histopathological factors in local recurrence and distant metastasis.
Sawalhi S; Al-Shatti M
Ann Saudi Med; 2013; 33(2):162-8. PubMed ID: 23563006
[TBL] [Abstract][Full Text] [Related]
36. Phyllodes tumors of the breast: The British Columbia Cancer Agency experience.
Rodrigues MF; Truong PT; McKevitt EC; Weir LM; Knowling MA; Wai ES
Cancer Radiother; 2018 Apr; 22(2):112-119. PubMed ID: 29523388
[TBL] [Abstract][Full Text] [Related]
37. Phyllodes tumours - a retrospective review of 83 clinical cases.
Mužlayová P; Coufal O; Fabian P; Svobodník A; Zapletal O
Rozhl Chir; 2019; 98(9):362-369. PubMed ID: 31698912
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
[TBL] [Abstract][Full Text] [Related]
39. Factors effective on recurrence and metastasis in phyllodes tumors.
Altiok M; Kurt F
Niger J Clin Pract; 2022 Apr; 25(4):425-431. PubMed ID: 35439900
[TBL] [Abstract][Full Text] [Related]
40. Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
Adam MJ; Bendifallah S; Kalhorpour N; Cohen-Steiner C; Ropars L; Mahmood A; Rousseau C; Leveque J; Nyangoh Timoh K; Der Some A; Ouldamer L; Legendre G; Ballester M; Daraï E; Canlorbe G; Lavoue V
Eur J Surg Oncol; 2018 Nov; 44(11):1743-1749. PubMed ID: 30195948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
